Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d4c5be4529e88ebafea5f274fc27f72 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/F24F5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B60H1-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/F25B23-00 |
filingDate |
2020-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fd26aba938e63dc6cdfc0f9ac1e8b86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24c885572a4c90ab267dbbc187c8fc17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8bdf1fd686718d413c66b9310c44a09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83542f127678c1a53ff2ca02fb40f4ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f7e90ea798382e24f66e5ac634f2268 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1636366527004481be8a9e01690412d2 |
publicationDate |
2022-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-114867622-A |
titleOfInvention |
Combination therapy involving diaryl macrocycles |
abstract |
The present disclosure relates to methods and compositions for treating cancer with a combination of a diaryl macrocycle and an inhibitor of MAPK/ERK kinases -1 and -2 (MEK1 and MEK2; MAP2K1 and MAP2K2), such as trametinib. |
priorityDate |
2019-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |